Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance ROCKVILLE, MD, October 4, 2023 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading,...
-
MaxCyte Reports Second Quarter and Half-Year 2023 Financial Results and Updates Full Year 2023 Guidance ROCKVILLE, MD, August 9, 2023 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading...
-
MaxCyte Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Guidance ROCKVILLE, MD, May 10, 2023 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading,...
-
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results 31% Total Revenue Growth for Full Year 2022 including 26% Core Business Revenue Growth and $4.6 million in...